Rosuvastatin to Lower Circulating Tissue Factor Bearing Microparticles in Metastatic Breast Cancer
NCT01299038
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
20
Enrollment
OTHER
Sponsor class
Conditions
Breast Cancer
Interventions
DRUG:
rosuvastatin
Sponsor
Beth Israel Deaconess Medical Center
Collaborators
[object Object]
[object Object]
[object Object]